These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9612710)

  • 1. [An investigation of the effect of H3-H3 peptide vaccine for preventing influenza virus infection in DQ6 mice].
    Matsuki N
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):171-9. PubMed ID: 9612710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of infection of influenza virus in DQ6 mice, a human model, by a peptide vaccine prepared according to the cassette theory.
    Matsuki N; Ogasawara K; Takami K; Namba K; Takahashi A; Fukui Y; Sasazuki T; Iwabuchi K; Good RA; Onoé K
    Vaccine; 1999 Mar; 17(9-10):1161-8. PubMed ID: 10195628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Induction of neutralizing antibodies against HIV-1 viruses in HLA-DQ6 mice by peptide vaccines].
    Takahashi A
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):147-56. PubMed ID: 9612708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of synthetic peptide vaccine against influenza--T cell epitope the hemagglutinin of A/Aichi/2/68(H3N2) influenza virus induced immune response in mice].
    Naruse H
    Hokkaido Igaku Zasshi; 1994 Jul; 69(4):811-20. PubMed ID: 7525436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of a peptide deduced from the influenza virus haemagglutinin that induces human class II-restricted T cell responses in DQ6 transgenic mice].
    Takami K
    Hokkaido Igaku Zasshi; 1995 Mar; 70(2):329-42. PubMed ID: 7774884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential peptide vaccine against two different strains of influenza virus isolated at intervals of about 10 years.
    Naruse H; Ogasawara K; Kaneda R; Hatakeyama S; Itoh T; Kida H; Miyazaki T; Good RA; Onoé K
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9588-92. PubMed ID: 7937811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DQ6 and HLA-DQ8 transgenic mice respond to ragweed allergens and recognize a distinct set of epitopes on short and giant ragweed group 5 antigens.
    Chapoval SP; Neeno T; Krco CJ; Marietta EV; Harders J; David CS
    J Immunol; 1998 Aug; 161(4):2032-7. PubMed ID: 9712076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of peptide vaccines inducing production of neutralizing antibodies against HIV-1 viruses in HLA-DQ6 mice.
    Takahashi A; Ogasawara K; Matsuki N; Fujinaga K; Nakaya T; Ikuta K; Auwanit W; Honda M; Fukui Y; Sasazuki T; Iwabuchi K; Onoé K
    Vaccine; 1998 Oct; 16(16):1537-43. PubMed ID: 9711801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
    Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
    Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E
    Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory.
    Naruse H; Ogasawara K; Takami K; Kajino K; Gotohda T; Itoh Y; Miyazaki T; Good RA; Onoè K
    Vaccine; 1994 Jul; 12(9):776-82. PubMed ID: 7526571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor.
    Bianchi E; Liang X; Ingallinella P; Finotto M; Chastain MA; Fan J; Fu TM; Song HC; Horton MS; Freed DC; Manger W; Wen E; Shi L; Ionescu R; Price C; Wenger M; Emini EA; Cortese R; Ciliberto G; Shiver JW; Pessi A
    J Virol; 2005 Jun; 79(12):7380-8. PubMed ID: 15919893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of T cell determinants on human type II collagen recognized by HLA-DQ8 and HLA-DQ6 transgenic mice.
    Krco CJ; Watanabe S; Harders J; Griffths MM; Luthra H; David CS
    J Immunol; 1999 Aug; 163(3):1661-5. PubMed ID: 10415072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A universal epitope-based influenza vaccine and its efficacy against H5N1.
    Adar Y; Singer Y; Levi R; Tzehoval E; Perk S; Banet-Noach C; Nagar S; Arnon R; Ben-Yedidia T
    Vaccine; 2009 Mar; 27(15):2099-107. PubMed ID: 19356612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
    Tamura S; Kurata T
    Jpn J Infect Dis; 2004 Dec; 57(6):236-47. PubMed ID: 15623947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant influenza A virus nucleoprotein is preferentially localized in the cytoplasm and its immunization in mice shows higher immunogenicity and cross-reactivity.
    Ohba K; Yoshida S; Zahidunnabi Dewan M; Shimura H; Sakamaki N; Takeshita F; Yamamoto N; Okuda K
    Vaccine; 2007 May; 25(21):4291-300. PubMed ID: 17403560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
    Szántó S; Bárdos T; Szabó Z; David CS; Buzás EI; Mikecz K; Glant TT
    Arthritis Rheum; 2004 Jun; 50(6):1984-95. PubMed ID: 15188376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
    Ichinohe T; Watanabe I; Tao E; Ito S; Kawaguchi A; Tamura S; Takahashi H; Sawa H; Moriyama M; Chiba J; Komase K; Suzuki Y; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2006 Jul; 78(7):954-63. PubMed ID: 16721854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
    Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.